NEW YORK (GenomeWeb News) – Absorption Systems of Exton, Pa. has won a grant from the US Food and Drug Administration to continue developing its line of cell-based tests to measure drug interactions in humans, the company said today.

The $417,000 Phase II Small Business Innovation Research grant will fund the development of the CellPort Technologies suite of in vitro test systems. These tests are designed to monitor interactions of drugs with a class of proteins called drug transporters, which mediate drug disposition throughout the body.